Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

Summary

The purpose of this study is to determine whether SF2a-TT15 (a monovalent synthetic carbohydrate-based conjugate Shigella vaccine) is safe and effective in the prevention of Shigella infection.

Timeline

Start

2020-03-02

Primary completion

2023-01-24

Completion

2024-01-25

Drugs

Indications